Tag Archives: Kimera Labs Inc

Focus on cell-free approaches offers expanded therapeutic potential for regenerative medicine applications. Kimera Labs Inc, a specialty contract research organization, today announced the creation of a 6,000 sq ft, ISO:9001 certified exosome production facility in Miramar, Florida. As an FDA ...

Read More »